-
Loading metrics
Safety and pharmacokinetics of GSK3494245, a highly selective Leishmaniasis kinetoplastid proteasome inhibitor for the treatment of visceral leishmaniasis: A Phase 1, randomized, single ascending dose escalation study in healthy participants
- Mischka Moodley,
- Michalis Kostapanos,
- Laura Iavarone,
- Marguerite Bracher,
- Silvia M. Lavezzi,
- Maria Davy,
- Pooja Singh,
- Ramya Bhat,
- Deborah Wong,
- Hema Sharma
x
-
- Published: May 13, 2026
- https://doi.org/10.1371/journal.pntd.0014181